Jagsonpal Pharmaceuticals Limited — Important, 13-03-2025: Updates

The Board of Directors of Jagsonpal Pharmaceuticals has approved changes in Key Management Personnel (KMPs) authorized for determining materiality and making disclosures to stock exchanges, following the appointment of Mr. Pratham Rawal as Company Secretary. The updated contact details for KMPs are now listed, which include Mr. Manish Gupta (Managing Director) and Mr. Sachin Jain (Chief Financial Officer) along with Mr. Rawal. This move enhances the governance framework and aligns with compliance obligations. Investors should note this change as it ensures transparency and efficient communication regarding material events or updates, contributing to the company's governance integrity and positive outlook.